The CB2 Cannabinoid System: A New Strategy in Neurodegenerative Disorder and Neuroinflammation
The neurodegenerative disorders such as Parkinson's disease (PD) or Alzheimer's disease (AD) are the most common forms of dementia and no pharmacological treatments are to date available for these diseases. Indeed, the only used drugs are symptomatic and no useful to block the progression...
Saved in:
Main Author: | Marialessandra Contino (auth) |
---|---|
Other Authors: | Nicola A. Colabufo (auth), Elena Capparelli (auth), Ashley I. Bush (auth) |
Format: | Book Chapter |
Published: |
Frontiers Media SA
2017
|
Subjects: | |
Online Access: | Get Fullteks DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alberta Oil and the Decline of Democracy in Canada
by: Edited by Meenal Shrivastava and Lorna Stefanick
Published: (2015) -
Chapter Life Cycle Inventory (LCI) Approach Used for Rare Earth Elements (REEs) from Monazite Material, Considering Uncertainty
by: Bieda, Bogusław
Published: (2019) -
Appetite and Satiety Control-Gut Mechanisms
Published: (2021) -
Cannabis : Neuropsychiatry and Its Effects on Brain and Behavior
Published: (2021) -
The Coevolution of IDO1 and AhR in the Emergence of Regulatory T Cells in Mammals
by: Ursula Grohmann
Published: (2016)